T2512 |
Mocetinostat
|
726169-73-9
|
99.37%
|
|
Mocetinostat (MG0103) is an orally available HDAC inhibitor with most potency for HDAC1 (IC50: 0.15 μM), 2- to 10- fold selectivity against HDAC2/3/11.
|
TN1911 |
Marein
|
535-96-6
|
99.34%
|
|
Marein shows neuroprotective effect on PC12 cell damage induced by methylglyoxal, which is due to a reduction of damage to mitochondria function and activation o...
|
T2140 |
Parthenolide
|
20554-84-1
|
99.33%
|
|
(-)-Parthenolide ((-)-Parthenolide), an inhibitor of the Nuclear Factor-κB Pathway, also promotes the ubiquitination of MDM2 and activates p53 cellular functions...
|
T6161 |
Tubastatin A Hydrochloride
|
1310693-92-5
|
99.25%
|
|
Tubastatin A Hydrochloride (TSA HCl) is an effective and specific HDAC6 inhibitor (IC50: 15 nM). It has selectivity (>1000-fold) against all other isozymes excep...
|
T6061 |
LMK-235
|
1418033-25-6
|
99.24%
|
|
LMK-235 is a potent HDAC inhibitor, and is used in cancer research.
|
T10244 |
ACY-1083
|
1708113-43-2
|
99.22%
|
|
ACY-1083 is a selective and brain-penetrating HDAC6 inhibitor (IC50: 3 nM) and effectively reverses chemotherapy-induced peripheral neuropathy.
|
T7052 |
Gnetol
|
86361-55-9
|
99.21%
|
|
Gnetol competitivity inhibits butyrylcholinesterase (IC50: 1.3 uM). Gnetol has a strong inhibitory effect on murine tyrosinase activity. Gnetol significantly sup...
|
T9148 |
KA2507
|
1636894-46-6
|
99.14%
|
|
KA2507 is a potent and selective HDAC6 inibitor with an IC50 of 2.5nM.
|
T73515 |
MC2590
|
2284460-01-9
|
99.14%
|
|
MC2590 is a potent and selective histone deacetylase (HDAC) inhibitor that inhibits HDAC1-3, -6, -8, and -10 activities, induces cell cycle arrest, and promotes ...
|
T6325 |
PCI-34051
|
950762-95-5
|
99.14%
|
|
PCI-34051 is an effective and selective HDAC8 inhibitor (IC50: 10 nM).
|
T2383 |
Panobinostat
|
404950-80-7
|
99.14%
|
|
Panobinostat (NVP-LBH589) is a broad-spectrum HDAC inhibitor (IC50=5 nM) with oral activity and non-selectivity. Panobinostat has antitumor activity and induces ...
|
T3108 |
CUDC-101
|
1012054-59-9
|
99.12%
|
|
CUDC-101 is a potent inhibitor of HDAC, EGFR and HER2 with IC50s of 4.4, 2.4 and 15.7 nM, respectively.
|
T77664 |
KH16
|
|
99.11%
|
|
KH16 is a potent HDAC inhibitor that specifically targets class I HDACs (HDAC1, HDAC2 and HDAC3) with IC50 values between 6 and 34 nM. KH16 is able to stimulate ...
|
T6233 |
Entinostat
|
209783-80-2
|
99.11%
|
|
Entinostat (MS-275) (MS-275) is an inhibitor of HDACs that inhibits HDAC1 and HDAC3 (IC50s: 0.18/0.74 μM).
|
T6286 |
RGFP966 (E-isomer)
|
1396841-57-8
|
99.1%
|
|
RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM, exhibits > 200-fold selectivity over other HDAC.
|
T10602L |
BRD 4354
|
315698-07-8
|
99.08%
|
|
BRD 4354 is an inhibitor of HDAC5 and HDAC9. For HDAC5 and HDAC9, the IC50s values are 0.85 and 1.88 μM, respectively.
|
T30579 |
BRD4097
|
1550053-19-4
|
99.08%
|
|
BRD4097, a negative control in the HDAC1/2/3/8 assay, is a selective histone deacetylase (HDAC3) inhibitor that can be used to protect b-cells and improve insuli...
|
T16936 |
SS-208
|
2245942-72-5
|
99.07%
|
|
SS-208 is a selective inhibitor of HDAC6 (IC50 = 12 nM) with anti-tumor activity. SS-208 shows selectivity over other HDAC subtypes.
|
T3661 |
Citarinostat
|
1316215-12-9
|
99.06%
|
|
ACY-241, also known as Citarinostat (ACY241), is a potent, selective and orally available histone deacetylase (HDAC) inhibitor, with potential antineoplastic act...
|
T3878 |
Raddeanin A
|
89412-79-3
|
99.05%
|
|
Raddeanin A (NSC-382873) has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.
|